BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
✓ FULLY PROFILED

Antazoline

229+ PubMed studies analyzed · BiohacksAI corpus v20260307-01

Antazoline 2D molecular structure
PubMed Studies
229+
Targets
9
Pathways
10
Molecular Targets

Molecular targets identified in BiohacksAI corpus. Click to explore all compounds affecting each target.

Biological Pathways
Biological Mechanisms

Biological mechanisms activated or modulated by Antazoline based on pathway and target analysis.

Health Goals

Health goals where Antazoline ranks among evidence-based compounds in the BiohacksAI corpus.

Related Conditions

Health conditions associated with the biological pathways influenced by Antazoline.

Similar Compounds

Explore compounds with similar target profiles and pathway overlap.

Find similar compounds to Antazoline
Data Source
Corpusv20260307-01
PubMed studies229
PubChem CID2200
SourcePubMed / NCBI · ChEMBL · Reactome · PubChem

All data is computationally derived from published research. Molecular structure images from PubChem (public domain). Not medical advice. Independent validation required.

This compound profile for Antazoline is generated from 229 PubMed-indexed studies. Key molecular targets include ADRA1A, ADRA2A, CYP2D6. Associated biological pathways: DOPAMINE_SEROTONIN, INSULIN_SIGNALING, INFLAMMATION. BiohacksAI does not provide medical advice. Consult a healthcare professional before starting any supplement regimen.